Physician profile
John Eifler
NPI 1821296005
$26,140.42
in general payments reported to CMS, 2019-2025
48 companies · $3,940 in 2025
The $3,940 reported for 2025 was more than what 89% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,331 · 2020: $886 · 2021: $7,161 · 2022: $1,863 · 2023: $1,848 · 2024: $9,111 · 2025: $3,940.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,656 · Consulting Fee: $3,270 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,432 · Travel and Lodging: $1,425 · Education: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,655.93 |
| Consulting Fee | $3,270.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,432.00 |
| Travel and Lodging | $1,425.40 |
| Education | $116.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $4,503.74 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Ferring Pharmaceuticals INC. | $3,243.96 | 2019-2025 | Adstiladrin |
| Medtronic, INC. | $3,223.58 | 2021-2025 | Interstim, Altaviva, Symplicity G3 |
| Janssen Scientific Affairs, LLC | $3,053.20 | 2024-2025 | Erleada, Akeega |
| Janssen Biotech, INC. | $1,649.61 | 2019-2025 | Erleada, Akeega |
| Myovant Sciences INC. | $1,332.60 | 2021-2022 | |
| Intuitive Surgical, INC. | $1,250.86 | 2024-2025 | |
| Urogen Pharma, INC. | $783.08 | 2020-2025 | Jelmyto |
| Teleflex LLC | $744.17 | 2020-2024 | Urolift |
| Medtronic USA, INC. | $706.29 | 2019-2020 | |
| Astellas Pharma US INC | $680.30 | 2019-2023 | Myrbetriq |
| Myriad Genetic Laboratories, INC. | $556.15 | 2020-2024 | Prolaris, Myrisk |
| Novartis Pharmaceuticals Corporation | $418.00 | 2020-2025 | |
| Boston Scientific Corporation | $311.00 | 2019-2023 | Rezum Generator |
| Histosonics, INC. | $305.46 | 2024-2025 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $285.29 | 2024-2025 | Illuccix |
| Sumitomo Pharma America, INC. | $281.86 | 2023-2025 | Gemtesa, Orgovyx |
| Sanara Medtech INC. | $250.12 | 2022-2025 | Celleraterx |
| Procept Biorobotics Corporation | $236.71 | 2021-2023 | Aquabeam Robotic System |
| Accord Healthcare, INC. | $216.83 | 2023-2025 | |
| Abbvie INC. | $209.24 | 2019-2025 | |
| Blue Earth Diagnostics | $191.70 | 2019-2021 | |
| Pfizer INC. | $184.87 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $177.32 | 2024-2025 | Lynparza, Imfinzi |
| Photocure INC | $134.96 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $132.14 | 2019-2024 | |
| Exelixis INC. | $121.86 | 2023 | Cabometyx |
| Siemens Medical Solutions USA, INC. | $116.63 | 2021 | |
| Endo Pharmaceuticals INC. | $112.98 | 2019-2023 | Aveed, Xiaflex |
| Calyxo, INC. | $97.93 | 2025 | Cvac Aspiration System |
| E.R. Squibb & Sons, L.L.C. | $89.66 | 2022-2023 | |
| Amgen INC. | $72.32 | 2019 | |
| Verity Pharmaceuticals INC. | $65.23 | 2025 | Trelstar, Tlando |
| Axonics, INC. | $63.39 | 2021 | |
| Antares Pharma, INC. | $63.02 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Integra Lifesciences Corporation | $46.92 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $39.31 | 2019-2020 | |
| Eisai INC. | $38.58 | 2020-2024 | |
| Progenics Pharmaceuticals, INC. | $29.25 | 2022-2023 | Pylarify |
| Tolmar, INC. | $20.85 | 2025 | Eligard, Jatenzo |
| Edap Technomed INC | $19.05 | 2025 | |
| Baxter Healthcare | $16.18 | 2024 | Floseal |
| Angiodynamics, INC. | $14.59 | 2022 | |
| Biotissue Holdings INC. | $13.82 | 2023 | |
| Baudax Bio INC. | $12.62 | 2021 | |
| Coloplast Corp | $12.09 | 2019 | |
| Zyla Life Sciences, INC. | $11.10 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$9,770.18 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Eifler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.